These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 18662736

  • 21. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.
    France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R, Vaccine Safety Datalink Team.
    Pediatrics; 2008 Mar; 121(3):e687-92. PubMed ID: 18310189
    [Abstract] [Full Text] [Related]

  • 22. Risk of serious neurologic disease after immunization of young children in Britain and Ireland.
    Ward KN, Bryant NJ, Andrews NJ, Bowley JS, Ohrling A, Verity CM, Ross EM, Miller E.
    Pediatrics; 2007 Aug; 120(2):314-21. PubMed ID: 17671057
    [Abstract] [Full Text] [Related]

  • 23. Clinical safety issues of measles, mumps and rubella vaccines.
    Afzal MA, Minor PD, Schild GC.
    Bull World Health Organ; 2000 Aug; 78(2):199-204. PubMed ID: 10743285
    [Abstract] [Full Text] [Related]

  • 24. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?
    Shoenfeld Y, Aron-Maor A.
    J Autoimmun; 2000 Feb; 14(1):1-10. PubMed ID: 10648110
    [Abstract] [Full Text] [Related]

  • 25. The first rapid onset optic neuritis after measles-rubella vaccination: case report.
    Arshi S, Sadeghi-Bazargani H, Ojaghi H, Savadi-Oskouei D, Hekmat S, Jastan M, Majidpour A, Shahizareh F.
    Vaccine; 2004 Sep 03; 22(25-26):3240-2. PubMed ID: 15308345
    [Abstract] [Full Text] [Related]

  • 26. Analysis of data from the CDC/FDA vaccine adverse event reporting system (1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA.
    Souayah N, Yacoub HA, Khan HM, Farhad K, Maybodi L, Qureshi AI, Menkes DL.
    J Clin Neurosci; 2012 Aug 03; 19(8):1089-92. PubMed ID: 22705140
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Epidemiological characteristics of Guillain-Barré syndrome in urban and rural areas in Beijing and Hebei, China].
    Hong X, Zhang Z, Wang J, Zhang B, Yin W, Zhang X, Tang X, Guo Y.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr 03; 22(2):115-9. PubMed ID: 12903510
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2006 Oct 20; 55(41):1120-4. PubMed ID: 17060898
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Measles in Poland in 2002].
    Czarkowski MP, Kondej B.
    Przegl Epidemiol; 2004 Oct 20; 58(1):21-7. PubMed ID: 15218638
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Guillain-Barré syndrome following influenza vaccination.
    Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT.
    JAMA; 2004 Nov 24; 292(20):2478-81. PubMed ID: 15562126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.